DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: News & Meetings
Latest announcements and gatherings
Rethinking ‘Rundle’s Curve’: How our Understanding of Thyroid Eye Disease (TED) Has Evolved
Our understanding of Thyroid Eye Disease (TED) has changed considerably over the last few years, driven primarily by new treatment options and research. This evolved understanding has prompted specialists in the field to reconsider the course of the disease and how to approach treatment.
Historically, TED has been considered a biphasic disease, using Rundle’s curve to show that the disease changes over time and then enters a stable phase. In this conventional time-based model, patients start with “active” or “acute” TED, where inflammatory signs and symptoms such as eye pain, swelling, proptosis and diplopia progress and may worsen. After a few years, the disease is traditionally thought to enter an “inactive” or “chronic” phase where signs, symptoms, and patient burden have been thought to be diminished.
Disclaimer: Horizon supports the mission of oneGRAVESvoice and has provided financial support for this platform. Horizon neither owns or controls this platform, and unless expressly stated otherwise, does not have editorial control over content or responsibility for any other information or services.


Related Content
-
Evidence & EducationPatients’ Perceptions and Views of Surgery and Radioiodine Ablation in the Definitive Management of GravesR...Background: Patients' perceptions and p...
-
People & PlacesThe Johns Hopkins Hospital – Thyroid and Parathyroid CenterAt John Hopkins Thyroid and Parathyroid ...
-
People & PlacesEuropean Thyroid AssociationThe European Thyroid Association's aims ...
-
Evidence & EducationPredicting Risk of Recurrent Thyrotoxicosis Following Thionamide Withdrawal in Graves’ DiseaseBackground/Aim: Thionamides are a safe ...
-
Evidence & EducationPost-Partum and Non-Post-Partum Relapsing Graves’ Hyperthyroidism Display Different Response to Anti-Thyroid D...Design: Graves’ disease (GD) patients...
-
Evidence & EducationThyroidectomy as Primary Treatment Optimizes Body Mass Index in Patients With HyperthyroidismObjective: The purpose of this study wa...
-
People & PlacesAugusta University Medical Center – Thyroid and Parathyroid CenterThe Thyroid and Parathyroid Center at Au...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.